Navigation Links
Experimental drug combination selectively destroys lymphoma cells
Date:2/6/2013

Laboratory experiments conducted by scientists at Virginia Commonwealth University Massey Cancer Center suggest that a novel combination of the drugs ibrutinib and bortezomib could potentially be an effective new therapy for several forms of blood cancer, including diffuse large B-cell lymphoma (DLBCL) and mantle cell lymphoma (MCL).

The study, published in the British Journal of Hematology, showed that the experimental drug combination killed cancer cells through a form of cell suicide known as apoptosis, but was relatively non-toxic to normal, healthy cells. Ibrutinib is a new agent that inhibits the B-cell receptor (BCR) signaling complex, which plays an important role in the survival of malignant B-cells. It has shown very promising initial results in the treatment of patients with B-cell malignancies, including chronic lymphocytic leukemia (CLL), DLBCL and MCL. The synergistic interaction of the two drugs proved lethal even to lymphoma cells that had become resistant to bortezomib, when used alone.

"Bortezomib is currently used to treat MCL and multiple myeloma, but, unfortunately, many patients develop resistance to the drug," says the study's principle investigator Steven Grant, M.D., Shirley Carter Olsson and Sture Gordon Olsson Chair in Oncology Research, associate director for translational research, program co-leader of Developmental Therapeutics and Cancer Cell Signaling research member at VCU Massey Cancer Center. "We are hopeful that this combination therapy may circumvent such resistance and eventually help fill an urgent need for more effective therapies for patients with these uncommon blood disorders."

With cultured DLBCL and MCL cells in laboratory experiments spearheaded by Girija Dasmahapatra, Ph.D., lead author of the study's manuscript and instructor in the Department of Internal Medicine at VCU School of Medicine, the scientists found that ibrutinib blocked several molecular pathways that the cancer ce
'/>"/>

Contact: John Wallace
wallacej@vcu.edu
804-628-1550
Virginia Commonwealth University
Source:Eurekalert  

Page: 1 2

Related biology news :

1. Nicole George wins 2012 Journal of Experimental Biology Outstanding Paper Prize
2. FASEB SRC announces conference registration open for: Genetic Recombination & Genome Rearrangements
3. TGen, Scottsdale Healthcare study shows drug combination extends pancreatic cancer patient survival
4. Cats are able to navigate complex combinations of wet and dry foods to achieve a consistent intake of protein, fat and carbohydrate
5. Combination of two pharmaceuticals proves effective in the treatment of multiple sclerosis
6. Hormone combination effective and safe for treating obesity in mice
7. Insecticide resistance caused by recombination of 2 genes
8. New line of approach for combination therapy against melanoma
9. New study finds a protein combination is best to consume post-workout for building muscle
10. Research breakthrough selectively represses the immune system
11. New way to kill lymphoma without chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Experimental drug combination selectively destroys lymphoma cells
(Date:1/22/2015)... , Jan. 13, 2015  Today, FreeWavz ( www.FreeWavz.com ... its crowdfunding campaign on Fundable, https://www.fundable.com/freewavz . ... of production capacity to meet customer demand. ... - http://photos.prnewswire.com/prnh/20150113/168790 Invented ...
(Date:1/22/2015)... 2015  BellBrook Labs, a leader in high throughput ... of a TR-FRET (time resolved Forster resonance energy ... a high throughput screening assay for glycosyltransferases and ... for sensitive detection of hundreds of human and ...
(Date:1/22/2015)... 20, 2015 NXT-ID, Inc. (NASDAQ: NXTD and NXTDW) ... on the recent success of the Wocket™ smart wallet at CES 2015 ... wallet was named as one of the "11 Hot Products at CES" ... Launched At CES So Far" by Newseveryday.com and "The top 10 gadgets ...
Breaking Biology News(10 mins):FreeWavz Launches on Fundable to Drive Speed-to-Market in 2015 2BellBrook Labs Launches a High Throughput Screening Assay for Glycosyltransferases with TR-FRET Readout 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 3
... appearance and nutritional content of gluten-free food products, a ... by 2017, according to a presentation today at the ... Food Expo in Chicago. An estimated one in ... by the ingestion of gluten peptides found in wheat, ...
... to be a proven strong nutrient-rich food providing essential ... some toxicologists still keep a watchful eye on safety, ... 2013 Institute of Food Technologists (IFT) Annual Meeting & ... evidence shows that health benefits derived from the consumption ...
... Major progress in tackling child undernutrition in some of the ... funding takes precedence, a new report from aid agency World ... die every year has decreased by half since 1990. Yet, ... this progress is under threat. Countries marred by conflict or ...
Cached Biology News:New technologies and ingredients provide better options for gluten-free eating 2Seafood still considered a good source of nutrients but consumers confused on safety 2
(Date:2/26/2015)... 26, 2015 According to a new ... Market For Transgenic Crops (Corn, Soybean, Cotton and Others), ... Size, Share, Growth, Trends and Forecast, 2013 – 2019,”the ... million in 2012 and is expected to reach USD ... 9.5% from 2013 to 2019. , Demand for ...
(Date:2/26/2015)... Grove, IL (PRWEB) February 26, 2015 ... month for the development of oncology drug substances. , ... start up of their new Potent Compound Suite (PCS) ... operating a 36,000 square foot, cGMP facility in Morton ... molecule cGMP manufacturing of potent compounds up to about ...
(Date:2/26/2015)... 26, 2015 Tauriga Sciences, Inc. (OTCQB: TAUG) ("Tauriga" ... interests in the natural wellness sector and in developing ... its products will be featured at the SEC Compliance ... th Annual Growth Stock Conference on March 8-11 ... Ritz Carlton Drive, Dana Point , ...
(Date:2/26/2015)...   Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX ... Cowen 35 th Annual Health Care Conference on Tuesday, ... Boston .  Lexicon management will provide an overview of ... of the presentation will be available through Lexicon,s website at ... be available at www.lexpharma.com until April 3, 2015. ...
Breaking Biology Technology:Global Agricultural Biotechnology Market is Expected to Reach USD 28,694.1 Million in 2019 : Transparency Market Research 2Global Agricultural Biotechnology Market is Expected to Reach USD 28,694.1 Million in 2019 : Transparency Market Research 3Regis Extends cGMP Services to Oncology Market 2SEC Compliance Featuring Products From Tauriga Sciences, Inc. at ROTH Capital Conference 2SEC Compliance Featuring Products From Tauriga Sciences, Inc. at ROTH Capital Conference 3SEC Compliance Featuring Products From Tauriga Sciences, Inc. at ROTH Capital Conference 4Lexicon To Present At The Cowen 35th Annual Health Care Conference 2
... Johnson Controls , a supplier of automotive ... analytic software to examine its processes. Jim Hayes, the ... from Intelligenxia, Inc. , a Florida-based company that ... for valuable data. , ,The software automatically categorizes words ...
... way to ensure the effectiveness of your companys next web site ... literally) through the process of paper prototyping. , ,Paper prototyping is ... creating rough sketches of a web site design and inviting some ... using their pen, instead of a mouse, to complete important tasks. ...
... to a dynamic start on Tuesday morning at the Hyatt ... representatives to a crash course in making a new company ... both veteran and novice business owners, by providing a loose ... ,Our purpose is to focus on what were doing here, ...
Cached Biology Technology:How Good Does Your Web Site Look on Paper? 2Entrepreneurs get crash course for building a successful company 2Entrepreneurs get crash course for building a successful company 3
... acid synthetic peptide whose sequence corresponds to residues 1-18 from rat ... carboxy terminus): M(1) - A - S - A - S ... P - R - D - A - A - D ... for neutralization and control experiments with the polyclonal antibody that reacts ...
... Kit enables complete conversion of unmethylated ... 6 hours. The highly sensitive method ... degradation and a spin-column-based purification and ... reliable results for all downstream applications. ...
... RNA sequences from high throughput synthesis are new ... LC Sciences. These products provide a large number ... sequences delivered in a microtube as a mixture ... verified RNA sequence. This is a custom product ...
... Hollandes is a fixative useful for ... fixation. It is stable and will decalcify ... with Hollande's can be stained successfully with ... the solution stabilizes red blood cell membranes ...
Biology Products: